Design Therapeutics, Inc. DSGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.71M-24.0% | -$69.79M-40.7% | -$67.45M-41.2% | -$63.49M-25.6% | -$56.2M+4.2% | ||
| $620K+1.3% | $622K+4.4% | $615K+5.1% | $613K+7.7% | $612K+11.1% | ||
| $14.93M+11.2% | $14.55M+11.3% | $14.59M+18.3% | $14.11M+13.6% | $13.43M+4.5% | ||
| -$54M-13.8% | -$54.36M-26.1% | -$52.25M-13.5% | -$50.64M+0.8% | -$47.46M+11.4% | ||
| $121K— | $193K— | —— | —— | —— | ||
| —— | —— | $36.33M— | —— | —— | ||
| $45.65M+8,747% | $25.74M+4,917% | $684K-8.9% | $648K-15.1% | $516K— | ||
| —— | —— | —— | —— | —— | ||
| -$54.12M-13.5% | -$54.55M-25.6% | -$52.41M-12.9% | -$50.78M+1.3% | -$47.67M+11.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Design Therapeutics, Inc. generate?
- Design Therapeutics, Inc. (DSGN) generated -$54.0M in operating cash flow over the trailing twelve months.
- What is Design Therapeutics, Inc.'s free cash flow?
- After $121.0K of capital expenditures, Design Therapeutics, Inc.'s free cash flow was -$54.1M over the trailing twelve months, down 13.5% year over year.
- Where does Design Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Design Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.